ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,315, issued on Aug. 4, was assigned to MILTENYI BIOTEC B.V. & Co. KG (Bergisch Gladbach, Germany).
"Method for transduction of t cells in the presence of malignant cells" was invented by Nicole Cordes (Bergisch Gladbach, Germany), Thomas Schaser (Bergisch Gladbach, Germany) and Andrew Kaiser (Bergisch Gladbach, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an in-vitro method of reducing the efficiency of transducing malignant cells of the blood system of a subject that are not derived from T cells with lentiviral vector particles without reducing the efficiency of transducing T cells in a sample comprising T ce...